Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
U.S. Opioids Market, By Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone) and Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment) and by Geography - Trends and Forecast to 2025

Published Date : Nov 2017

Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromo

Coherent Market Insights
Global Medical Adhesives and Sealants Market, by Product Type (Synthetic and Natural), by Application (Internal, External and Dental), by End-use Industry (Hospitals, Clinics, Ambulatory Surgical Centers, Dental Clinics, and Others) and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

Medical Adhesives and Sealants Market – Providing Adhesive Solutions Post Surgeries Medical adhesives and sealants are commonly employed in medical practices for appliance bonding and surgical procedure

Coherent Market Insights
Global Clinical Nutrition Market by Product Type (Infant Nutrition (Milk based, soy-based, Organic, Probiotics/ Prebiotics and Others), Enteral Nutrition (Standard Nutrition, Disease Specific) Parenteral Nutrition (Amino acids, Fats and Carbohydrates), and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

Clinical Nutrition – The New Tradition is Good Nutrition Clinical nutrition products are aimed at maintaining a nutritional balance in patients, by providing sufficient amounts of nutrients, such as vit

Coherent Market Insights
Anti-epileptic Drugs for Pediatrics Market by Drug Type (1st generation, 2nd generation, and 3rd generation), and Region - Global Industry Insights, Trends, and Forecast, 2017-25

Published Date : Sep 2017

Anti-Epileptic Drugs for Pediatrics Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Depending on the area of the brain obstructed by se

Coherent Market Insights
Global Myelodysplastic Syndrome (MDS) Treatment Market, By Drug (Azacitidine, Lenalidomide, Decitabine, Deferasirox), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025

Published Date : Sep 2017

Myelodysplastic Syndrome Treatment Market Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells call

Coherent Market Insights
Global Gunshot Injuries Treatment Market, By Product (XStat, Airwrap, Floseal), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Sep 2017

Gunshot Injuries Treatment Market: Life Saviors at the Battlefield Gunshot injury, also referred to as ballistic trauma, is a form of physical trauma caused when a bullet, knife or any sharp projectile is sho

Coherent Market Insights
Global Epistaxis Market, By Product Type (Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Sep 2017

Epistaxis - A Common Clinical Condition Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive

Coherent Market Insights
Global Wilson’s Disease Treatment Market, By Treatment (Medications, others), Distribution Channel (Government, Hospitals, Medical Practitioners), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Sep 2017

Wilson's Disease Treatment Market Wilson’s disease is a genetic disorder caused by the loss of function of the ATP7B copper-binding protein that leads to impaired copper transport and excretion, which r

Coherent Market Insights
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Drugs, Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)) - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : May 2017

Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years

Coherent Market Insights
Adrenocortical Carcinoma Treatment Market, by Therapy Type (Chemotherapy Targeted Therapy, Adjuvant Therapy, and Radiotherapy), by Disease Type (Localized Adrenocortical Carcinoma and Metastatic Adrenocortical Carcinoma), by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2018

Adrenocortical carcinoma is a rare cancer affecting the outer layer of the adrenal glands, which are responsible for producing certain hormones and maintaining optimum blood pressure levels. Adrenocortical carcinoma is relatively frequent in children compared to other

Coherent Market Insights
Dravet Syndrome Treatment Market, by Treatment Type (Drugs (Anticonvulsant, Benzodiazepines, and Others) and Device (Vagal Nerve Stimulation)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2018

Dravet syndrome (DS), also known as epilepsy with polymorphic seizures and polymorphic epilepsy in infancy (PMEI), is a severe and rare genetic dysfunction of the brain (epileptic encephalopathy). It usually begins in first year of life and remains throughout lifetime

Coherent Market Insights
Burkitt Lymphoma Treatment Market, by Therapy Type (Chemotherapy, Targeted Therapy, and Radio-immunotherapy), by Route of Administration (Oral and Intravenous), by Disease Type (Endemic, Sporadic, and Immunodeficiency-associated), by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2018

Burkitt lymphoma is a cancer of the lymphatic system, which develops from abnormal B lymphocytes and is characterized by rapid growth. Burkitt lymphoma usually causes lymph node enlargement in various parts of the body, including spleen, liver, bone marrow, and centra

Coherent Market Insights
Systemic Lupus Erythematosus Treatment Market, by Treatment Type (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs, Cytotoxic and Immunosuppressive Drugs, and Biologics), By Route of Administration (Intravenous, Sub-cutaneous, Oral, and Topical), By Distribution Channel (Retail Pharmacy and Online Pharmacy) and by Geography - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017-2025

To Be Published : May 2018

Systemic Lupus Erythematosus (SLE) is chronic autoimmune disorder. It is characterized by excess production of the antibodies that attacks body’s own cells and vital organs. Various symptoms associated with the disease includes joint pain, swelling, rashes over

Coherent Market Insights
Primary Biliary Cirrhosis Drugs Market, By Drug (Ursodeoxycholic Acid (Ursodiol), Obeticholic Acid (Ocaliva), and Others (Anti-Inflamatory, Anti-Pruritics and Anti-Histamines)), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017-2025

To Be Published : May 2018

Primary biliary cirrhosis, known as primary biliary cholangitis is a chronic liver disease, which causes liver inflammation, fibrosis, and obstruction in the bile duct leading to destruction of small bile ducts within liver. Cause for primary biliary cirrhosis can be

Coherent Market Insights
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market, By Drugs (Zyvox, Cubicin, Sivextro, Daptomycin, Tygacil, Teflaro, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Geography - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017-2025

To Be Published : May 2018

Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of a

Coherent Market Insights
Trigeminal Neuralgia Treatment Market, by Treatment (Drug Type and Surgery), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, to 2025

To Be Published : May 2018

Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain disorder that affects the fifth cranial or trigeminal nerve. It causes inflammatory conditions due to systemic diseases including Lyme disease, sarcoidosis, and multiple sclerosis. There is als

Coherent Market Insights
Dedifferentiated Liposarcoma Treatment Market, by Treatment Type (Chemotherapy, Immunotherapy, and Radiation Therapy), by End User (Hospitals, Multispecialty Clinics & Cancer Treatment, and Rehabilitation Centers), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Liposarcoma refers to one of the most commonly diagnosed type of soft tissue sarcomas. It is a type of cancer that originates from the fat cells in deep tissues. On the other hand, dedifferentiated Liposarcoma is the least common subtypes among all types of sarcomas a

Coherent Market Insights
Anaplastic Astrocytoma Treatment Market, by Product Type (Alkylating Agents, Kinase Inhibitors, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Astrocytoma is a medical condition that develops from astrocytes, a star-shaped brain cells. The disease has been categorized into four different groups based on reproduction rate of the cell, and its capability to spread in nearby tissues. Grades I and Grades II astr

Coherent Market Insights
Acute Invasive Aspergillosis Treatment Market, by Drug Type (Antifungals (Voriconazole, Capsofungin, Itraconazole, Isavuconazole, Amphotericin B, and Others) Corticosteroids (Prednisolone, Prednisone, and Methylprednisolone)), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Acute Invasive Aspergillosis is an acute infection or fungal growth, which arises due to Aspergillus fungus. Almost everyone comes in contact with the Aspergillus fungus as it is found on decaying vegetation and dead leaves, however, not everyone is susceptible to the

Coherent Market Insights
Botulinum Toxin Market, by Product Type (Botulinum Toxin Type A, and Botulinum Toxin Type B), by Application (Cosmetics, Dystonia, Chronic Migraines, Spasticity, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Botulinum toxin is a product produced by naturally occurring Clostridium botulinum bacteria. This bacteria is found in soil and marine sediments and can produce harmful neurotoxin botulinum toxin. Botulinum toxin is a ‘blocking agent’ which inhibits the re

Coherent Market Insights
Measles, Mumps and Rubella (MMR) Vaccines Market, by Product Type (Monovalent, and Combinational (Divalent, Trivalent, and Others)) and by End Users (Hospitals, Healthcare Centers, and Others) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : May 2018

Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are

Coherent Market Insights
Fibrosarcoma Drugs Market by Type (Adult Fibrosarcoma and Infantile Fibrosarcoma) by Active Ingredient (Doxorubicin Hydrocholride, Ifosfamide, Dacarbazine, Pazopanib Hydrochloride, and Other Active Ingredient) by Route of Administration (Oral and Injectable) by Distribution Channel (Hospital Pharmacies and Retail Pharmacies) - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017- 2025

To Be Published : May 2018

Fibrosarcoma is a rare type of soft tissue malignant tumour composed solely of fibre-forming connective tissue called as fibroblasts. Although, this condition can occur at any age, it is commonly diagnosed between the age of 30-60 years. Patients suffering from geneti

Coherent Market Insights
Clostridium Difficile Infection Treatment Market - by Drug Class (Metronidazole, Fidoxamycin, Vancomycin, and Other Drug Class), by Route of Administration (Oral and Intravenous/Parenteral), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Clostridium difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets transmitted through fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due to healthcare associated infection with clinica

Coherent Market Insights
Osteonecrosis Treatment Market - By Drug Class (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti-Coagulant, and Other Drugs) and By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Osteonecrosis is a disease in which bone cells dies or bones collapse due to lack of blood flow to the bones. It is also known as avascular necrosis, aseptic necrosis or ischemic necrosis. Osteonecrosis is most commonly developed in hip bone (femur) or knees, while le

Coherent Market Insights
Thrombocytopenia Treatment Market, By Drug Class (Glucocorticoids, Lysosomal Enzyme, and Platelet Stimulating Agent), and By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Thrombocytopenia is a disorder in which a patient has low level of platelets in the blood. The major causes of thrombocytopenia are inefficient production of platelets, platelet splenic sequestration, and accelerative destruction of platelets. The most common ineffect

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.